Sign Up to like & get
recommendations!
2
Published in 2022 at "Inflammatory Bowel Diseases"
DOI: 10.1093/ibd/izac174
Abstract: Abstract Background The safety of a third dose of SARS-CoV-2 mRNA vaccination in patients with inflammatory bowel disease is unknown. Methods We compared symptoms following a third SARS-CoV-2 mRNA vaccine dose with symptoms after the…
read more here.
Keywords:
vaccination patients;
patients inflammatory;
inflammatory bowel;
symptoms third ... See more keywords